HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
LGI3
leucine rich repeat LGI family member 3
Chromosome 8 Β· 8p21.3
NCBI Gene: 203190Ensembl: ENSG00000168481.10HGNC: HGNC:18711UniProt: Q8N145
19PubMed Papers
21Diseases
0Drugs
11Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
GO:0005615juxtaparanode region of axonsynaptic vesicleregulation of exocytosisintellectual developmental disorder with muscle tone abnormalities and distal skeletal defectsneurodegenerative diseaseperipheral neuropathyAbruptio Placentae
✦AI Summary

LGI3 (leucine rich repeat LGI family member 3) functions as a secreted regulatory protein with diverse roles in neuronal exocytosis, keratinocyte biology, and cellular signaling. In the nervous system, LGI3 associates with syntaxin 1, a key SNARE component, and attenuates calcium-evoked glutamate release from synaptosomes, suggesting it negatively regulates neuronal exocytosis 1. The protein is predominantly expressed in brain tissue with developmentally regulated patterns 2. In skin biology, LGI3 acts as a keratinocyte-derived cytokine that promotes cell differentiation via Akt pathway activation and enhances keratinocyte migration in high-glucose environments through Ξ²-catenin accumulation 34. LGI3 also stimulates melanogenesis and shows reduced expression in vitiligo patients 5. The protein responds to inflammatory stimuli, being secreted by keratinocytes following LPS exposure through TRIF-dependent NF-ΞΊB signaling and binding to ADAM22 receptor 6. In cancer contexts, LGI3 exhibits tumor-suppressive properties in pancreatic adenocarcinoma but promotes progression in TFE3-rearranged renal cell carcinoma through GEMIN6/AURKB signaling 78. These findings establish LGI3 as a multifunctional secreted protein important for neuronal regulation, skin homeostasis, and disease pathogenesis.

Sources cited
1
LGI3 associates with syntaxin 1 and attenuates calcium-evoked glutamate release from synaptosomes
PMID: 18760330
2
LGI3 is predominantly expressed in brain with developmentally regulated patterns
PMID: 16545924
3
LGI3 promotes keratinocyte differentiation via Akt pathway activation
PMID: 30091803
4
LGI3 enhances keratinocyte migration in high-glucose environments through Ξ²-catenin accumulation
PMID: 35751164
5
LGI3 stimulates melanogenesis and shows reduced expression in vitiligo patients
PMID: 31644616
6
LGI3 is secreted following LPS exposure through TRIF-dependent NF-ΞΊB signaling and binds to ADAM22
PMID: 31627033
7
LGI3 exhibits tumor-suppressive properties in pancreatic adenocarcinoma
PMID: 38394487
8
LGI3 promotes TFE3-rearranged renal cell carcinoma progression through GEMIN6/AURKB signaling
PMID: 40849584
Disease Associationsβ“˜21
intellectual developmental disorder with muscle tone abnormalities and distal skeletal defectsOpen Targets
0.69Moderate
neurodegenerative diseaseOpen Targets
0.24Weak
peripheral neuropathyOpen Targets
0.20Weak
Abruptio PlacentaeOpen Targets
0.19Weak
cardiovascular diseaseOpen Targets
0.18Weak
non-small cell lung carcinomaOpen Targets
0.09Suggestive
gliomaOpen Targets
0.08Suggestive
VitiligoOpen Targets
0.07Suggestive
Genetic renal or urinary tract malformationOpen Targets
0.04Suggestive
male reproductive system diseaseOpen Targets
0.04Suggestive
polycystic kidney disease 5Open Targets
0.04Suggestive
esophageal adenocarcinomaOpen Targets
0.03Suggestive
Barrett's esophagusOpen Targets
0.03Suggestive
congenital hydronephrosisOpen Targets
0.03Suggestive
focal segmental glomerulosclerosisOpen Targets
0.03Suggestive
focal segmental glomerulosclerosis 7Open Targets
0.03Suggestive
renal dysplasiaOpen Targets
0.03Suggestive
congenital anomalies of kidney and urinary tract 1Open Targets
0.03Suggestive
neoplasmOpen Targets
0.03Suggestive
Alzheimer diseaseOpen Targets
0.03Suggestive
Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defectsUniProt
Pathogenic Variants11
NM_139278.4(LGI3):c.494+1G>CPathogenic
Peripheral nerve hyperexcitability syndrome|Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects
β˜…β˜…β˜†β˜†2022
NM_139278.4(LGI3):c.625C>T (p.Gln209Ter)Likely pathogenic
Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects
β˜…β˜†β˜†β˜†2023β†’ Residue 209
NM_139278.4(LGI3):c.271C>T (p.Gln91Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 91
NM_139278.4(LGI3):c.335C>A (p.Ser112Ter)Pathogenic
Peripheral nerve hyperexcitability syndrome|Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects
β˜…β˜†β˜†β˜†2022β†’ Residue 112
NM_139278.4(LGI3):c.991G>A (p.Asp331Asn)Pathogenic
Peripheral nerve hyperexcitability syndrome|Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects
β˜…β˜†β˜†β˜†2022β†’ Residue 331
NM_139278.4(LGI3):c.1117del (p.Trp373fs)Pathogenic
Peripheral nerve hyperexcitability syndrome|Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects
β˜…β˜†β˜†β˜†2022β†’ Residue 373
NM_139278.4(LGI3):c.422T>A (p.Leu141His)Pathogenic
Peripheral nerve hyperexcitability syndrome
β˜…β˜†β˜†β˜†2022β†’ Residue 141
NM_139278.4(LGI3):c.830-1G>APathogenic
Peripheral nerve hyperexcitability syndrome
β˜…β˜†β˜†β˜†2022
NM_139278.4(LGI3):c.102dup (p.Lys35fs)Pathogenic
Peripheral nerve hyperexcitability syndrome
β˜…β˜†β˜†β˜†2022β†’ Residue 35
NM_139278.4(LGI3):c.937del (p.Thr313fs)Pathogenic
Peripheral nerve hyperexcitability syndrome|Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects
β˜…β˜†β˜†β˜†2022β†’ Residue 313
NC_000008.11:g.22146137_22152989delPathogenic
Peripheral nerve hyperexcitability syndrome
β˜…β˜†β˜†β˜†2022
View on ClinVar β†—
Related Genes
ADAM23Protein interaction93%ADAM22Protein interaction93%RAB37Shared pathway50%RAB26Shared pathway33%SEPTIN1Shared pathway33%RAB3DShared pathway25%
Tissue Expression6 tissues
Brain
100%
Lung
5%
Heart
1%
Ovary
0%
Liver
0%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
LGI3ADAM23ADAM22RAB37RAB26SEPTIN1RAB3D
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q8N145
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.07LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.84 [0.66–1.07]
RankingsWhere LGI3 stands among ~20K protein-coding genes
  • #14,456of 20,598
    Most Researched19
  • #2,806of 5,498
    Most Pathogenic Variants11
  • #10,766of 17,882
    Most Constrained (LOEUF)1.07
Genes detectedLGI3
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
LGI3 is secreted and binds to ADAM22 via TRIF-dependent NF-ΞΊB pathway in response to LPS in human keratinocytes.
PMID: 31627033
Cytokine Β· 2020
1.00
2
Mouse LGI3 gene: expression in brain and promoter analysis.
PMID: 16545924
Gene Β· 2006
0.90
3
Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients.
PMID: 31644616
An Bras Dermatol Β· 2019
0.80
4
LGI3 promotes the progression of TFE3-rearranged renal cell carcinoma through GEMIN6/AURKB axis.
PMID: 40849584
Oncogene Β· 2025
0.70
5
Leucine rich repeat LGI family member 3: Integrative analyses support its prognostic association with pancreatic adenocarcinoma.
PMID: 38394487
Medicine (Baltimore) Β· 2024
0.60